Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Seagen Inc.
Genmab
Seagen Inc.
Fulgent Pharma LLC.
University of Chicago
AstraZeneca
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Medical College of Wisconsin
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Gustave Roussy, Cancer Campus, Grand Paris
West China Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
University Health Network, Toronto
Cedars-Sinai Medical Center
Northwell Health
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
Bayer
Gilead Sciences
Massachusetts Eye and Ear Infirmary
Arcus Biosciences, Inc.
Erasca, Inc.
R-Pharm
China Medical University Hospital
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
PT. Prodia Stem Cell Indonesia
South Egypt Cancer Institute
M.D. Anderson Cancer Center
University of Colorado, Denver
UNC Lineberger Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Bayer
Royal College of Surgeons, Ireland
Abramson Cancer Center at Penn Medicine